NICE Medicines Framework Agreement

NICE Medicines Framework Agreement

National Framework. Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012.UK-London: services provided by medical personnel

2012/S 118-195530

Contract notice

Services

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

National Institute of Health and Clinical Excellence
MidCity Place, 71 High Holborn,
Contact point(s): Yvonne Tutt
WC1V 6NA London
UNITED KINGDOM
Telephone: +44 1618703197
E-mail: yvonne.tutt@nice.org.uk

Internet address(es):

General address of the contracting authority: http://www.nice.org.uk

Further information can be obtained from: The above mentioned contact point(s)

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)

Tenders or requests to participate must be sent to: The above mentioned contact point(s)

I.2)Type of the contracting authority

Body governed by public law
I.3)Main activity

Health
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: no

Section II: Object of the contract

II.1)Description
II.1.1)Title attributed to the contract by the contracting authority:

Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012.
II.1.2)Type of contract and location of works, place of delivery or of performance

Services
Service category No 27: Other services
Main site or location of works, place of delivery or of performance: Throughout England. There are 10 Regions that need to be covered and these are:-.
Region 1 = North East England.
Region 2 = North West England.
Region 3 = Yorkshire and Humber.
Region 4 = West Midlands.
Region 5 = East Midlands.
Region 6 = East of England.
Region 7 = London.
Region 8 = South East England.
Region 9 = South Central.
Region 10 = South West England.
NUTS code UK

II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

The notice involves the establishment of a framework agreement
II.1.4)Information on framework agreement

Framework agreement with several operators
maximum number of participants to the framework agreement envisaged: 10
Duration of the framework agreement

Duration in years: 24
Justification for a framework agreement, the duration of which exceeds four years: N/A.
Estimated total value of purchases for the entire duration of the framework agreement

Estimated value excluding VAT: 390 000,00 GBP
Frequency and value of the contracts to be awarded: Annual estimated value for 10 facilitators = £195K.

II.1.5)Short description of the contract or purchase(s)

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
II.1.6)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

II.1.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): no
II.1.8)Lots

This contract is divided into lots: yes
Tenders may be submitted for one or more lots
II.1.9)Information about variants

Variants will be accepted: no
II.2)Quantity or scope of the contract
II.2.1)Total quantity or scope:

There will be 10 lots for this work and these are based on the Regions that Facilitators are required for. The Regions are:-.
Region 1 = North East England.
Region 2 = North West England.
Region 3 = Yorkshire and Humber.
Region 4 = West Midlands.
Region 5 = East Midlands.
Region 6 = East of England.
Region 7 = London.
Region 8 = South East England.
Region 9 = South Central.
Region 10 = South West England.
The purpose of the framework is to appoint a maximum of 10 facilitators, each for a maximum of 50 days (no less than 40 days) to support the delivery of NICE Medicines and Prescribing Centre Facilitator programme across England. The Facilitators provide support to health care staff to implement improvements in the use of medicines across the NHS, including the provision of information on medicines,prescribing advice, training and education, governance and decision making.
For all Lots, Facilitators will also be required to undertake training, complete reports and attend meetings with NICE Medicines & Prescribing Centre as part of a performance monitoring process.
Facilitators shall be appointed for two years October 2012 to end Sept 2014.
Estimated value excluding VAT: 390 000,00 GBP
II.2.2)Information about options

Options: no
II.2.3)Information about renewals

This contract is subject to renewal: no
II.3)Duration of the contract or time limit for completion

Duration in months: 24 (from the award of the contract)

Information about lots

Lot No: 1 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 1 -North East England

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 1 North East England only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 2 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 2-North West England

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 2 North West England only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 3 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 3-Yorkshire and Humber

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 3 Yorkshire and Humber only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 4 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 4-West Midlands

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 4 WEST MIDLandS only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 5 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 5-East Midlands

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 5 EAST MIDLandS only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 6 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 6-East of England

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 6 EAST OF ENGLand only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 7 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 7-London

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 7 London only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 8 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 8-South East England

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 8 SOUTH EAST ENGLand only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 9 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 9-South Central

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 9 SOUTH CENTRAL only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.
Lot No: 10 Lot title: Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012 Region 10-South West England

1)Short description

The NICE Medicines and Prescribing Centre Facilitator programme supports Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation. To achieve this aim, NICE Medicines and Prescribing Centre Facilitators each focus on one of ten geographical Regions across England; working with locally defined networks including emerging commissioning consortia, PCT clusters, and other existing NHS organisations, (such as Secondary Care and Mental Health Trusts) in order to:
— Support the identification of current issues relating to the use of medicines,
— Support the development of action plans against agreed priority areas,
— Support the use of prescribing data to drive improvement towards agreed goals,
— Provide advice and support to key individuals to allow them to cascade relevant information within their own organisations,
— Signpost individuals or organisations to further support from NICE,
— Facilitate the identification and sharing of good practice.
This Lot is for Region 10 South West England only.
2)Common procurement vocabulary (CPV)

85141000, 80561000, 85100000, 85140000

3)Quantity or scope

The scope of activity associated with the support of Regional implementation of the QIPP (Quality, Innovation, Productivity and Prevention) in relation to prescribing and medicines optimisation includes supporting the implementation of NICE guidance related to medicines and prescribing.
Aspects of medicines optimisation associated with the role include an emphasis on:
— quality and productivity associated with the use of medicines, including quality in prescribing (for all prescribers, including non-medical),
— managing the introduction of new medicines, including local decision-making,
— reducing patient safety incidents involving medicines,
— advising health care professionals and managers on supporting patients taking medicines in the community,
— safe and efficient systems and processes, including those for controlled drugs,
— reducing waste – associated with both the use of medicines, and the waste associated with inefficient systems and processes,
— the appropriate use and procurement of homecare medicines,
— engaging with patients and the public,
— promoting the changes to the BNF(British National Formulary), especially its development into a primarily electronic publication,
— applying evidence-informed decision-making.
This list is not exhaustive however, as Regional approaches to prescribing and medicines optimisation may vary, and therefore necessitate alternative emphases.
Please note: the role of NICE Medicines and Prescribing Centre Facilitator in each of the ten Regions, must be held by a named, dedicated individual.
Therefore, although tenders are invited from organisations as well as individuals, organisations must propose a named individual for each Region they intend to tender for.
The contractor will work with named individuals from the NICE Medicines and Prescribing Centre to implement the NICE Medicines and Prescribing Centre Facilitator programme.
Contractor must be available to commence work from October 2012.
Estimated value excluding VAT: 19 500,00 GBP
4)Indication about different date for duration of contract or starting/completion
5)Additional information about lots

When responding to this OJEU notice, please state clearly in your email which Region you require the documentation for. Your email must also contain your name, contact address & telephone number and the name of the organisation on whose behalf you are submitting the interest. If an individual, please ensure you supply your name, contact address & telephone number.
Please note that bids for each Region will be assessed seperately so if submitting proposals for more than one Region, you must submit a seperate bid for each Region tendered for.

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Deposits and guarantees required:
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:

Joint and Severable.
III.1.4)Other particular conditions

The performance of the contract is subject to particular conditions: no
III.2)Conditions for participation
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers
III.2.2)Economic and financial ability
III.2.3)Technical capacity
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts
III.3.1)Information about a particular profession

Execution of the service is reserved to a particular profession: no
III.3.2)Staff responsible for the execution of the service

Legal persons should indicate the names and professional qualifications of the staff responsible for the execution of the service: yes

Section IV: Procedure

IV.1)Type of procedure
IV.1.1)Type of procedure

Open
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate
IV.1.3)Reduction of the number of operators during the negotiation or dialogue
IV.2)Award criteria
IV.2.1)Award criteria

The most economically advantageous tender in terms of the criteria stated below

1. Financial Stability. Weighting 100

2. Project Plan. Weighting 30

3. Change Management & Facilitation skills. Weighting 20

4. Expertise. Weighting 30

5. Quality Assurance. Weighting 10

6. Project Cost. Weighting 10

IV.2.2)Information about electronic auction

An electronic auction will be used: no
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority:

Provision of Facilitators for NICE Medicines and Prescribing Centre framework agreement NMPC-FAC-06-2012
IV.3.2)Previous publication(s) concerning the same contract
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document

Time limit for receipt of requests for documents or for accessing documents: 9.8.2012 – 17:00
Payable documents: no
IV.3.4)Time limit for receipt of tenders or requests to participate

17.8.2012 – 17:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up

English.
IV.3.7)Minimum time frame during which the tenderer must maintain the tender

in days: 180 (from the date stated for receipt of tender)
IV.3.8)Conditions for opening tenders

Date: 20.8.2012 – 09:00
Persons authorised to be present at the opening of tenders: no

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no
VI.2)Information about European Union funds
VI.3)Additional information

The purpose of the framework is to appoint a maximum of 10 facilitators, each for a maximum of 50 days (no less than 40 days) per year to support the delivery of NICE Medicines and Prescribing Centre Facilitator programme across England. The Facilitators provide support to health care staff to implement improvements in the use of medicines across the NHS, including the provision of information on medicines, prescribing advice, training and education, governance and decision making.
Bidders are required to state in their proposals their first, second and third choice of Regions. NICE will create a primary, secondary and tertiary supplier list, with those from the second and third lists being called upon to undertake the facilitator role in those Regions where no bid or successful bid was received from the first tier.
For all Lots -each contractor will be from a multidisciplinary healthcare professional background, with specialist knowledge of prescribing and medicines optimisation, and experienced in change management, facilitation and training.
Tenders from individuals, individual organisations or consortia of organisations are welcomed. Please note that where bids are received from consortia of organisations, in line with public sector procurement guidelines, NICE will only contract with the lead bidder in the event of a consortia bid being succesful. BIdders providing tenders in response to this work must include the name of a dedicated person nominated for the role of NICE Medicines and Prescribing Centre Facilitator.
Respondents to this advert must clearly state in their initial contact email what Region they are requesting tender pack(s) for.
VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures

National Institute for Health and Clinical Excellence
Mid City Place 71 High Holborn
WC1V 6NA London
UNITED KINGDOM

VI.4.2)Lodging of appeals

Precise information on deadline(s) for lodging appeals: NICE will incorporate a minimum 10 calendar day standstill period at the point information on the award of the contract is communicated to tenders. This Period allows unsuccessful tenderers to seek further debriefing from the contracting authority before the contract is entered into. Applicants have 2 working days from the notification of the award decision to request additional debriefing and that information has to be provided a minimum of 3 working days before the expiry of the standstill period. Such additional information should be requested from the contracting authority named in section l.1. If an appeal regarding the award of a contract has not been successfully resolved the Public Contracts Regulations 2006 (SI2006 No5.) provide for aggrieved parties who have been harmed or are at risk of harm by breach of the rules to take action in the High Court (England, Wales and Northern Ireland). Any such action must be brought promptly (generally within three months). Where a contract has not been entered.
Into, the Court may order the setting aside of the award decision or order the authority to amend any document and may award damages. If the contract has been entered into the Court may only award damages.
VI.4.3)Service from which information about the lodging of appeals may be obtained
VI.5)Date of dispatch of this notice:

21.6.2012